M&A - ORASURE TECHNOLOGIES INC
Form Type: 8-K/A
Filing Date: 2025-03-07
Corporate Action: Acquisition
Type: Update
Accession Number: 000111646325000008
Filing Summary: OraSure Technologies, Inc. filed an amended Current Report on Form 8-K/A to supplement the original report from December 26, 2024, regarding its acquisition of Sherlock Biosciences, Inc. This acquisition occurred on December 19, 2024, as per a Merger Agreement between the two companies. The amendment provides additional financial information required by the SEC, detailing historical audited financial statements of Sherlock for the year ended December 31, 2023, and for the nine months ended September 30, 2024, as well as pro forma combined financial statements for the companies. The report also includes notes and independent auditor’s reports and presents this financial information for informational purposes, indicating that these figures do not necessarily reflect actual or projected operational outcomes of the combined entity.
Document Link: View Document
Additional details:
Historical Audited Financials: Audited financial statements of Sherlock as of and for the fiscal year ended December 31, 2023
Pro Forma Financial Information: Unaudited pro forma combined financial information of OraSure and Sherlock as of September 30, 2024
Comments
No comments yet. Be the first to comment!